said the non-implementation of the policy, which could transform Nigeria’s pharmaceutical industry by reducing production costs and making drugs more affordable, has contributed to persistently ...

Vertex Pharmaceuticals’ (NASDAQ:VRTX) investigational non-opioid drug, suzetrigine, has met the primary endpoint in a mid-stage study in people with painful lumbosacral radiculopathy (LSR).

Dec 19 (Reuters) - Vertex Pharmaceuticals (VRTX.O), opens new tab said on Thursday its experimental non-opioid drug met the main goal of a mid-stage study but showed little difference versus a ...

In the last years, only few studies in literature have focused on the use and abuse of benzodiazepines (BZDs) in sport ... One of the important points that emerged from their stories was that their ...